Larson Yi Insider Trades

Insider Trading History

Track insider trading activity for Larson Yi. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $254k 24,150 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98.5k 24,150 shares
$4.08
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $242k 23,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$284k 23,000 shares
$12.36
$10.51
RayzeBio
RayzeBio RYZB
Director
Holding Value $0 0 shares
Last Trade
Sep 14, 2023 Sale
No data
No data
$62.49
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $226k 21,520 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 21,520 shares
$7.84
$10.51
LianBio
LianBio LIAN
Chief Financial Officer
Holding Value $104k 325,901 shares
Last Trade
Mar 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$561k 325,901 shares
$1.72
$0.32
LianBio
LianBio LIAN
Chief Financial Officer
Holding Value $148k 464,099 shares
Last Trade
Jan 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23M 464,099 shares
$2.66
$0.32
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Holding Value $226k 21,520 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.7k 21,520 shares
$3.61
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $226k 21,520 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.8k 21,520 shares
$3.43
$10.51
LianBio
LianBio LIAN
Chief Financial Officer
Holding Value $384k 1,202,841 shares
Last Trade
Dec 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.7k 5,996 shares
$11.95
$0.32
LianBio
LianBio LIAN
Chief Financial Officer
Holding Value $382k 1,196,845 shares
Last Trade
Oct 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.32
LianBio
LianBio LIAN
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 29, 2021 Sale
No data
No data
$0.32
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Holding Value $226k 21,520 shares
Last Trade
Jun 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$595k 21,520 shares
$27.66
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Holding Value $226k 21,520 shares
Last Trade
Apr 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$880k 25,293 shares
$34.80
$10.51
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Financial Officer
Holding Value $1.57M 20,775 shares
Last Trade
Feb 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.91M 20,775 shares
$140.01
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Financial Officer
Holding Value $1.28M 17,002 shares
Last Trade
Feb 02, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.88M 14,298 shares
$131.56
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Financial Officer
Holding Value $1.21M 16,002 shares
Last Trade
Feb 02, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.86M 14,298 shares
$130.14
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Financial Officer
Holding Value $21.3M 282,397 shares
Last Trade
Feb 02, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.88M 14,298 shares
$131.56
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Financial Officer
Holding Value $22.4M 296,695 shares
Last Trade
Feb 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.95M 15,702 shares
$124.46
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Financial Officer
Holding Value $1.39M 18,406 shares
Last Trade
Feb 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.95M 15,702 shares
$124.46
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Financial Officer
Holding Value $1.03M 13,623 shares
Last Trade
Feb 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.94M 15,702 shares
$123.62
$75.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up